4//SEC Filing
Colleran David 4
Accession 0001171843-25-001468
CIK 0000898437other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:18 PM ET
Size
9.2 KB
Accession
0001171843-25-001468
Insider Transaction Report
Form 4
Colleran David
EVP, General Counsel, Corp Sec
Transactions
- Exercise/Conversion
Common Stock
2025-03-11+7,663→ 45,649 total - Exercise/Conversion
Restricted Stock Unit
2025-03-11−7,663→ 0 totalExercise: $0.00→ Common Stock (7,663 underlying) - Tax Payment
Common Stock
2025-03-11$16.79/sh−2,250$37,778→ 43,399 total
Footnotes (4)
- [F1]Reflects the third and final vesting installment of RSUs granted on March 11, 2022.
- [F2]Reflects an aggregate of 2,250 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2025.
- [F3]Reflects the closing price of ANIK common stock on March 11, 2025, the trading day to which the vesting of RSUs gave rise to tax withholding obligations.
- [F4]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001646558
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:18 PM ET
- Size
- 9.2 KB